Follow:
RSS
Email
Twitter
Curaxis Pharmaceutical Corp. :: Alzheimer's News, Insight, and Information
  • Home
  • About Us
  • Media
  • Uncategorized

Archive for May, 2010

  • Education Can Delay the Onset of Dementia on May 31st, 2010
  • Herbal Supplement Sellers Dispense Dangerous Advice, False Claims on May 28th, 2010
  • Recognizing changes related to Alzheimer’s on May 28th, 2010
  • Occasional drink may protect against Alzheimer’s Disease on May 24th, 2010
  • ‘Brain power’ pills raise patients’ hopes, physicians’ worries on May 23rd, 2010
  • ‘Beer belly’ linked to Alzheimer’s disease on May 21st, 2010
  • Study revealed the link between Alzheimer’s disease and Down syndrome on May 21st, 2010
  • Alzheimer’s costs to soar without effective drugs on May 19th, 2010
  • Repeated Exposure to Pesticides Increases Alzheimer’s Disease Risk on May 19th, 2010
  • The Unfortunate NIH Report on Alzheimer’s Disease on May 19th, 2010
« Older Entries

  • Recent Articles

    • Alzheimer’s brain tangles offer clue to worsening
    • Cognitive Impairment Strikes Men More
    • Exercise Protects Against Alzheimer’s
    • Spinal taps may be useful in predicting brain disorders
    • New Study Explores Link Between Type 2 Diabetes, Alzheimer’s
  • Categories

  • Archives

    • September 2010 (3)
    • August 2010 (11)
    • July 2010 (17)
    • June 2010 (20)
    • May 2010 (20)
    • April 2010 (19)
    • March 2010 (16)
    • February 2010 (8)
    • January 2010 (16)
    • December 2009 (17)
    • November 2009 (1)
  • Curaxis Pharmaceutical Corp.

    Curaxis Pharmaceutical Corporation is a specialty company dedicated to finding cures for major age-related diseases with it initial focus is Alzheimer’s Disease (or AD). For more, visit www.curaxispharma.com

  • Follow Us On Twitter

    • News:: New Study Explores Link Between Type 2 Diabetes, Alzheimer's http://bit.ly/bDgU67
    • News:: Alzheimer's drug could put the brakes on deadly disease http://bit.ly/dgEAY0
    • News:: New Alzheimer's test http://blog.curaxispharma.com/2010/08/17/new-alzheimers-test/

About

Curaxis Pharmaceutical Corporation is a specialty pharmaceutical company dedicated to finding cures for major age-related diseases. Our initial focus is Alzheimer’s Disease (or AD). Our lead product is a patented treatment that has shown the potential for treating and halting the progression of this devastating disease. Today, over 5,300,000 Americans suffer with Alzheimer’s Disease. It is estimated that more than $100 billion is spent annually in the United States to treat and care for those with this ailment. Sadly, these numbers are growing every day as the situation for many patients and their families grows desperate, despite the millions of dollars spent annually to find the answer to effectively treating this disease.
  • Videos

Search

Copyright © 2012 Curaxis Pharmaceutical Corp.